Two Japanese Universities Confirm Depression Drug Paxil Treats Neuropathic Pain
This article was originally published in PharmAsia News
According to research conducted by psychosomatic medicine professor Kazunori Mine of Fukuoka University, and neuropharmacology professor Kazuhide Inoue of Kyushu University, the depression drug Paxil (paroxetine) was found to treat neuropathic pain, a continuous sharp pain even after direct pain-causing factors have been treated. In 2003, Inoue discovered protein P2×4, which relates to signaling and is found in spinal marrow microglial cells and causes the disease. Paroxetine is believed to constrain the mechanism of action of P2×4. Rats with neuropathic pain symptoms were observed to have drastically reduced pain following administration of Paxil. (Click for more-Japanese language
You may also be interested in...
A new report focused on the European market says that winning trust is the key to taking AI adoption to the next stage. That approach was praised by MedTech Europe CEO Serge Bernasconi.
As the transition period following the UK’s withdrawal from the European Union draws to a close, cosmetics industry stakeholders are following final trade negotiations while readying themselves for new regulatory complexities.
Purdue’s opioid settlement is making headlines for the size of the financial penalty. But the plan to re-imagine Purdue as a ‘public benefit company’ could have far-reaching significance for the industry – if it ever gets off the ground.